Tenet Healthcare Gains 2.6% YTD, Outpacing Industry Amid Ambulatory Growth

Zacks Investment Research··Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Tenet Healthcare shares have risen 2.6% year-to-date, outperforming the industry's 5.5% decline, as the company benefits from expanding adjusted admissions and strong Ambulatory Care segment performance. The Zacks Consensus Estimate for current-year earnings is $17.61 per share, reflecting 5% year-over-year growth, with two upward revisions in the past 60 days and an average earnings surprise of 20.6% over the last four quarters. Revenue is projected at $22.02 billion, a 3.3% increase, supported by higher patient revenue per adjusted admission and a shift toward higher-acuity services. The Ambulatory Care segment, which included interests in 541 ambulatory surgery centers and 26 surgical hospitals as of March 31, 2026, saw net operating revenues rise 10.6% year over year in the first quarter of 2026, following gains of 14.1% in 2025 and 17.3% in 2024. However, operating expenses increased 4.6% year over year in the first quarter of 2026 after a 20.6% jump in 2025, driven by labor costs, medical supply inflation, and higher patient acuity, which may pressure margins.

Impact on assets 4

Health Care▲ · 2 stocks
Tenet Healthcare Corporation
THC
▲ PositiveDemandrelevance

Strong Ambulatory Care segment growth with rising net operating revenues and expanding adjusted admissions

Aging Population▲ · 1 stocks
Biotech & Genomic Medicine▲ · 1 stocks